Chang, Y., Keramatnia, F., Ghate, P. S., Nishiguchi, G., Gao, Q., Iacobucci, I., . . . Mullighan, C. G. (2023). The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia. Blood, 142(7), 629. https://doi.org/10.1182/blood.2022017813
Citácia podle Chicago (17th ed.)Chang, Yunchao, et al. "The Orally Bioavailable GSPT1/2 Degrader SJ6986 Exhibits In vivo Efficacy in Acute Lymphoblastic Leukemia." Blood 142, no. 7 (2023): 629. https://doi.org/10.1182/blood.2022017813.
Citácia podľa MLA (8th ed.)Chang, Yunchao, et al. "The Orally Bioavailable GSPT1/2 Degrader SJ6986 Exhibits In vivo Efficacy in Acute Lymphoblastic Leukemia." Blood, vol. 142, no. 7, 2023, p. 629, https://doi.org/10.1182/blood.2022017813.
Upozornenie: Tieto citáce sú generované automaticky. Nemusia byť úplne správne podľa citačných pravidiel..